tiprankstipranks
Trending News
More News >
Telo Genomics Corp (TSE:TELO)
:TELO
Canadian Market

Telo Genomics Corp (TELO) Financial Statements

Compare
21 Followers

Telo Genomics Corp Financial Overview

Telo Genomics Corp's market cap is currently C$4.52M. The company's EPS TTM is C$-0.005; its P/E ratio is -2.38; Telo Genomics Corp is scheduled to report earnings on March 2, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 25Sep 23Jun 22Sep 20Jun 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -14.45KC$ -39.54KC$ -33.11KC$ -62.23KC$ -64.72K
Operating IncomeC$ -2.70MC$ -2.72MC$ -2.82MC$ -1.25MC$ -1.31M
EBITDAC$ -2.69MC$ -2.67MC$ -2.78MC$ -1.01MC$ -1.15M
Net IncomeC$ -2.72MC$ -2.71MC$ -2.82MC$ -1.07MC$ -1.24M
Balance Sheet
Cash & Short-Term InvestmentsC$ 789.29KC$ 796.02KC$ 2.67MC$ 3.64MC$ 920.98K
Total AssetsC$ 911.30KC$ 965.64KC$ 2.93MC$ 3.84MC$ 1.17M
Total DebtC$ 0.00C$ 0.00C$ 32.50KC$ 40.00KC$ 40.00K
Net DebtC$ -789.29KC$ -796.02KC$ -2.64MC$ -3.60MC$ -880.98K
Total LiabilitiesC$ 396.32KC$ 375.59KC$ 312.87KC$ 153.66KC$ 393.42K
Stockholders' EquityC$ 514.98KC$ 590.06KC$ 2.61MC$ 3.69MC$ 775.25K
Cash Flow
Free Cash FlowC$ -2.33MC$ -2.46MC$ -2.70MC$ -1.11MC$ -1.13M
Operating Cash FlowC$ -2.33MC$ -2.46MC$ -2.63MC$ -1.10MC$ -1.12M
Investing Cash FlowC$ -3.25KC$ -5.12KC$ -69.06KC$ -9.31KC$ -8.67K
Financing Cash FlowC$ 2.33MC$ 587.05KC$ 2.68MC$ 3.83MC$ 2.03M
Currency in CAD

Telo Genomics Corp Earnings and Revenue History

Telo Genomics Corp Debt to Assets

Telo Genomics Corp Cash Flow

Telo Genomics Corp Forecast EPS vs Actual EPS